Purchases and Sales Made in Q2 2022 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q2 2022. The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-67.5KClosed |
$540K - $1.01M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-300K- 8.92% |
$2.4M - $4.51M
|
3.07M
$158M
|
|
|
Aug 11, 2022
Q2 2022
|
Versant Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-618KClosed |
$4.94M - $9.27M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-746K- 60.23% |
$5.97M - $11.2M
|
493K
$25.4M
|
|
|
Aug 15, 2022
Q2 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.53M- 68.53% |
$12.2M - $23M
|
702K
$36.2M
|